APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-opioid Analgesic Patch

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Non-opioid Analgesic Patch Market Analysis and Forecast 2026-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchNon-opioid Analgesic Patch Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-opioid Analgesic Patch Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Non-opioid Analgesic Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-opioid Analgesic Patch Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-opioid Analgesic Patch Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Non-opioid Analgesic Patch market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Non-opioid Analgesic Patch include Acorda Therapeutics, Inc, Allergan, Endo International plc, Hisamitsu Pharmaceutical Co.,Inc, IBSA Institut Biochimque SA, Teh Seng Pharmaceutical Mfg, Teikoku Seiyaku Co., Ltd., GlaxoSmithKline Plc and Pfizer, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Non-opioid Analgesic Patch, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Non-opioid Analgesic Patch, also provides the revenue of main regions and countries. Of the upcoming market potential for Non-opioid Analgesic Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-opioid Analgesic Patch revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non-opioid Analgesic Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Non-opioid Analgesic Patch revenue, projected growth trends, production technology, application and end-user industry.

Non-opioid Analgesic Patch Segment by Company

Acorda Therapeutics, Inc

Allergan

Endo International plc

Hisamitsu Pharmaceutical Co.,Inc

IBSA Institut Biochimque SA

Teh Seng Pharmaceutical Mfg

Teikoku Seiyaku Co., Ltd.

GlaxoSmithKline Plc

Pfizer, Inc.

Mylan N.V.

Non-opioid Analgesic Patch Segment by Type

Capsaicin Patches

Lidocaine Patches

Diclofenac Patches

Methyl Salicylate Patches

Ketoprofen Patches

Others

Non-opioid Analgesic Patch Segment by Application

Hospital Pharmacies

Online Pharmacies

Independent Pharmacies & Drug Stores

Non-opioid Analgesic Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-opioid Analgesic Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-opioid Analgesic Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-opioid Analgesic Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Non-opioid Analgesic Patch in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Non-opioid Analgesic Patch company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-opioid Analgesic Patch revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-opioid Analgesic Patch Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Capsaicin Patches Major Player Table 3. Lidocaine Patches Major Player Table 4. Diclofenac Patches Major Player Table 5. Methyl Salicylate Patches Major Player Table 6. Ketoprofen Patches Major Player Table 7. Others Major Player Table 8. Global Non-opioid Analgesic Patch Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Hospital Pharmacies Major Player Table 10. Online Pharmacies Major Player Table 11. Independent Pharmacies & Drug Stores Major Player Table 12. Non-opioid Analgesic Patch Industry Trends Table 13. Non-opioid Analgesic Patch Industry Drivers Table 14. Non-opioid Analgesic Patch Industry Opportunities and Challenges Table 15. Non-opioid Analgesic Patch Industry Restraints Table 16. Global Non-opioid Analgesic Patch Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Non-opioid Analgesic Patch Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Non-opioid Analgesic Patch Market Share by Region (2021-2026) Table 19. Global Non-opioid Analgesic Patch Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Non-opioid Analgesic Patch Market Share by Region (2027-2032) Table 21. Global Non-opioid Analgesic Patch Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Non-opioid Analgesic Patch Revenue Market Share by Players (2021-2026) Table 23. Global Non-opioid Analgesic Patch Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Non-opioid Analgesic Patch Key Players Headquarters & Area Served Table 25. Global Non-opioid Analgesic Patch Players, Product Type & Application Table 26. Global Non-opioid Analgesic Patch Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Non-opioid Analgesic Patch by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Non-opioid Analgesic Patch Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Non-opioid Analgesic Patch Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Non-opioid Analgesic Patch Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Non-opioid Analgesic Patch Revenue Market Share by Type (2021-2026) Table 33. Global Non-opioid Analgesic Patch Revenue Market Share by Type (2027-2032) Table 34. Global Non-opioid Analgesic Patch Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Non-opioid Analgesic Patch Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Non-opioid Analgesic Patch Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Non-opioid Analgesic Patch Revenue Market Share by Application (2021-2026) Table 38. Global Non-opioid Analgesic Patch Revenue Market Share by Application (2027-2032) Table 39. Acorda Therapeutics, Inc Company Information Table 40. Acorda Therapeutics, Inc Business Overview Table 41. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Product Portfolio Table 43. Acorda Therapeutics, Inc Recent Development Table 44. Allergan Company Information Table 45. Allergan Business Overview Table 46. Allergan Non-opioid Analgesic Patch Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Allergan Non-opioid Analgesic Patch Product Portfolio Table 48. Allergan Recent Development Table 49. Endo International plc Company Information Table 50. Endo International plc Business Overview Table 51. Endo International plc Non-opioid Analgesic Patch Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Endo International plc Non-opioid Analgesic Patch Product Portfolio Table 53. Endo International plc Recent Development Table 54. Hisamitsu Pharmaceutical Co.,Inc Company Information Table 55. Hisamitsu Pharmaceutical Co.,Inc Business Overview Table 56. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Product Portfolio Table 58. Hisamitsu Pharmaceutical Co.,Inc Recent Development Table 59. IBSA Institut Biochimque SA Company Information Table 60. IBSA Institut Biochimque SA Business Overview Table 61. IBSA Institut Biochimque SA Non-opioid Analgesic Patch Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. IBSA Institut Biochimque SA Non-opioid Analgesic Patch Product Portfolio Table 63. IBSA Institut Biochimque SA Recent Development Table 64. Teh Seng Pharmaceutical Mfg Company Information Table 65. Teh Seng Pharmaceutical Mfg Business Overview Table 66. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product Portfolio Table 68. Teh Seng Pharmaceutical Mfg Recent Development Table 69. Teikoku Seiyaku Co., Ltd. Company Information Table 70. Teikoku Seiyaku Co., Ltd. Business Overview Table 71. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Product Portfolio Table 73. Teikoku Seiyaku Co., Ltd. Recent Development Table 74. GlaxoSmithKline Plc Company Information Table 75. GlaxoSmithKline Plc Business Overview Table 76. GlaxoSmithKline Plc Non-opioid Analgesic Patch Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. GlaxoSmithKline Plc Non-opioid Analgesic Patch Product Portfolio Table 78. GlaxoSmithKline Plc Recent Development Table 79. Pfizer, Inc. Company Information Table 80. Pfizer, Inc. Business Overview Table 81. Pfizer, Inc. Non-opioid Analgesic Patch Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Pfizer, Inc. Non-opioid Analgesic Patch Product Portfolio Table 83. Pfizer, Inc. Recent Development Table 84. Mylan N.V. Company Information Table 85. Mylan N.V. Business Overview Table 86. Mylan N.V. Non-opioid Analgesic Patch Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Mylan N.V. Non-opioid Analgesic Patch Product Portfolio Table 88. Mylan N.V. Recent Development Table 89. North America Non-opioid Analgesic Patch Revenue by Type (2021-2026) & (US$ Million) Table 90. North America Non-opioid Analgesic Patch Revenue by Type (2027-2032) & (US$ Million) Table 91. North America Non-opioid Analgesic Patch Revenue by Application (2021-2026) & (US$ Million) Table 92. North America Non-opioid Analgesic Patch Revenue by Application (2027-2032) & (US$ Million) Table 93. North America Non-opioid Analgesic Patch Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Non-opioid Analgesic Patch Revenue by Country (2021-2026) & (US$ Million) Table 95. North America Non-opioid Analgesic Patch Revenue by Country (US$ Million) & (2027-2032) Table 96. Europe Non-opioid Analgesic Patch Revenue by Type (2021-2026) & (US$ Million) Table 97. Europe Non-opioid Analgesic Patch Revenue by Type (2027-2032) & (US$ Million) Table 98. Europe Non-opioid Analgesic Patch Revenue by Application (2021-2026) & (US$ Million) Table 99. Europe Non-opioid Analgesic Patch Revenue by Application (2027-2032) & (US$ Million) Table 100. Europe Non-opioid Analgesic Patch Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Non-opioid Analgesic Patch Revenue by Country (2021-2026) & (US$ Million) Table 102. Europe Non-opioid Analgesic Patch Revenue by Country (US$ Million) & (2027-2032) Table 103. China Non-opioid Analgesic Patch Revenue by Type (2021-2026) & (US$ Million) Table 104. China Non-opioid Analgesic Patch Revenue by Type (2027-2032) & (US$ Million) Table 105. China Non-opioid Analgesic Patch Revenue by Application (2021-2026) & (US$ Million) Table 106. China Non-opioid Analgesic Patch Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Non-opioid Analgesic Patch Revenue by Type (2021-2026) & (US$ Million) Table 108. Asia Non-opioid Analgesic Patch Revenue by Type (2027-2032) & (US$ Million) Table 109. Asia Non-opioid Analgesic Patch Revenue by Application (2021-2026) & (US$ Million) Table 110. Asia Non-opioid Analgesic Patch Revenue by Application (2027-2032) & (US$ Million) Table 111. Asia Non-opioid Analgesic Patch Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Asia Non-opioid Analgesic Patch Revenue by Region (US$ Million) & (2021-2026) Table 113. Asia Non-opioid Analgesic Patch Revenue by Region (US$ Million) & (2027-2032) Table 114. SAMEA Non-opioid Analgesic Patch Revenue by Type (2021-2026) & (US$ Million) Table 115. SAMEA Non-opioid Analgesic Patch Revenue by Type (2027-2032) & (US$ Million) Table 116. SAMEA Non-opioid Analgesic Patch Revenue by Application (2021-2026) & (US$ Million) Table 117. SAMEA Non-opioid Analgesic Patch Revenue by Application (2027-2032) & (US$ Million) Table 118. SAMEA Non-opioid Analgesic Patch Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. SAMEA Non-opioid Analgesic Patch Revenue by Country (2021-2026) & (US$ Million) Table 120. SAMEA Non-opioid Analgesic Patch Revenue by Country (US$ Million) & (2027-2032) Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Non-opioid Analgesic Patch Image Figure 2. Global Non-opioid Analgesic Patch Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-opioid Analgesic Patch Market Size Share 2021 VS 2025 VS 2032 Figure 4. Capsaicin Patches Image Figure 5. Lidocaine Patches Image Figure 6. Diclofenac Patches Image Figure 7. Methyl Salicylate Patches Image Figure 8. Ketoprofen Patches Image Figure 9. Others Image Figure 10. Global Non-opioid Analgesic Patch Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Non-opioid Analgesic Patch Market Size Share 2021 VS 2025 VS 2032 Figure 12. Hospital Pharmacies Image Figure 13. Online Pharmacies Image Figure 14. Independent Pharmacies & Drug Stores Image Figure 15. Global Non-opioid Analgesic Patch Market Size (US$ Million) & (2021-2032) Figure 16. Global Non-opioid Analgesic Patch Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Non-opioid Analgesic Patch Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Non-opioid Analgesic Patch Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Non-opioid Analgesic Patch Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Non-opioid Analgesic Patch Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Non-opioid Analgesic Patch Revenue Market Share by Type (2021-2032) Figure 23. Global Non-opioid Analgesic Patch Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Non-opioid Analgesic Patch Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Non-opioid Analgesic Patch Revenue Market Share by Application (2021-2032) Figure 26. North America Non-opioid Analgesic Patch Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Non-opioid Analgesic Patch Revenue Share by Type (2021-2032) Figure 28. North America Non-opioid Analgesic Patch Revenue Share by Application (2021-2032) Figure 29. North America Non-opioid Analgesic Patch Revenue Share by Country (2021-2032) Figure 30. United States Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Non-opioid Analgesic Patch Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Non-opioid Analgesic Patch Revenue Share by Type (2021-2032) Figure 35. Europe Non-opioid Analgesic Patch Revenue Share by Application (2021-2032) Figure 36. Europe Non-opioid Analgesic Patch Revenue Share by Country (2021-2032) Figure 37. Germany Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Non-opioid Analgesic Patch Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Non-opioid Analgesic Patch Revenue Share by Type (2021-2032) Figure 47. China Non-opioid Analgesic Patch Revenue Share by Application (2021-2032) Figure 48. Asia Non-opioid Analgesic Patch Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Non-opioid Analgesic Patch Revenue Share by Type (2021-2032) Figure 50. Asia Non-opioid Analgesic Patch Revenue Share by Application (2021-2032) Figure 51. Asia Non-opioid Analgesic Patch Revenue Share by Region (2021-2032) Figure 52. Japan Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Non-opioid Analgesic Patch Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Non-opioid Analgesic Patch Revenue Share by Type (2021-2032) Figure 60. SAMEA Non-opioid Analgesic Patch Revenue Share by Application (2021-2032) Figure 61. SAMEA Non-opioid Analgesic Patch Revenue Share by Country (2021-2032) Figure 62. Brazil Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Non-opioid Analgesic Patch Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Capsaicin Patches
  • Lidocaine Patches
  • Diclofenac Patches
  • Methyl Salicylate Patches
  • Ketoprofen Patches
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Independent Pharmacies & Drug Stores
Companies covered
  • Acorda Therapeutics, Inc
  • Allergan
  • Endo International plc
  • Hisamitsu Pharmaceutical Co.,Inc
  • IBSA Institut Biochimque SA
  • Teh Seng Pharmaceutical Mfg
  • Teikoku Seiyaku Co., Ltd.
  • GlaxoSmithKline Plc
  • Pfizer, Inc.
  • Mylan N.V.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Non-opioid Analgesic Patch Market by Type
  3. 1.2.1 Global Non-opioid Analgesic Patch Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Capsaicin Patches
  5. 1.2.3 Lidocaine Patches
  6. 1.2.4 Diclofenac Patches
  7. 1.2.5 Methyl Salicylate Patches
  8. 1.2.6 Ketoprofen Patches
  9. 1.2.7 Others
  10. 1.3 Non-opioid Analgesic Patch Market by Application
  11. 1.3.1 Global Non-opioid Analgesic Patch Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Hospital Pharmacies
  13. 1.3.3 Online Pharmacies
  14. 1.3.4 Independent Pharmacies & Drug Stores
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Non-opioid Analgesic Patch Market Dynamics
  1. 2.1 Non-opioid Analgesic Patch Industry Trends
  2. 2.2 Non-opioid Analgesic Patch Industry Drivers
  3. 2.3 Non-opioid Analgesic Patch Industry Opportunities and Challenges
  4. 2.4 Non-opioid Analgesic Patch Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Non-opioid Analgesic Patch Market Perspective (2021-2032)
  2. 3.2 Global Non-opioid Analgesic Patch Growth Trends by Region
  3. 3.2.1 Global Non-opioid Analgesic Patch Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Non-opioid Analgesic Patch Market Size by Region (2021-2026)
  5. 3.2.3 Global Non-opioid Analgesic Patch Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Non-opioid Analgesic Patch Revenue by Players
  2. 4.1.1 Global Non-opioid Analgesic Patch Revenue by Players (2021-2026)
  3. 4.1.2 Global Non-opioid Analgesic Patch Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Non-opioid Analgesic Patch Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Non-opioid Analgesic Patch Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Non-opioid Analgesic Patch Key Players Headquarters & Area Served
  7. 4.4 Global Non-opioid Analgesic Patch Players, Product Type & Application
  8. 4.5 Global Non-opioid Analgesic Patch Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Non-opioid Analgesic Patch Market CR5 and HHI
  11. 4.6.3 2025 Non-opioid Analgesic Patch Tier 1, Tier 2, and Tier 3
5 Non-opioid Analgesic Patch Market Size by Type
  1. 5.1 Global Non-opioid Analgesic Patch Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Non-opioid Analgesic Patch Revenue by Type (2021-2032)
  3. 5.3 Global Non-opioid Analgesic Patch Revenue Market Share by Type (2021-2032)
6 Non-opioid Analgesic Patch Market Size by Application
  1. 6.1 Global Non-opioid Analgesic Patch Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Non-opioid Analgesic Patch Revenue by Application (2021-2032)
  3. 6.3 Global Non-opioid Analgesic Patch Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Acorda Therapeutics, Inc
  2. 7.1.1 Acorda Therapeutics, Inc Company Information
  3. 7.1.2 Acorda Therapeutics, Inc Business Overview
  4. 7.1.3 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Product Portfolio
  6. 7.1.5 Acorda Therapeutics, Inc Recent Developments
  7. 7.2 Allergan
  8. 7.2.1 Allergan Company Information
  9. 7.2.2 Allergan Business Overview
  10. 7.2.3 Allergan Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Allergan Non-opioid Analgesic Patch Product Portfolio
  12. 7.2.5 Allergan Recent Developments
  13. 7.3 Endo International plc
  14. 7.3.1 Endo International plc Company Information
  15. 7.3.2 Endo International plc Business Overview
  16. 7.3.3 Endo International plc Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Endo International plc Non-opioid Analgesic Patch Product Portfolio
  18. 7.3.5 Endo International plc Recent Developments
  19. 7.4 Hisamitsu Pharmaceutical Co.,Inc
  20. 7.4.1 Hisamitsu Pharmaceutical Co.,Inc Company Information
  21. 7.4.2 Hisamitsu Pharmaceutical Co.,Inc Business Overview
  22. 7.4.3 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Product Portfolio
  24. 7.4.5 Hisamitsu Pharmaceutical Co.,Inc Recent Developments
  25. 7.5 IBSA Institut Biochimque SA
  26. 7.5.1 IBSA Institut Biochimque SA Company Information
  27. 7.5.2 IBSA Institut Biochimque SA Business Overview
  28. 7.5.3 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  29. 7.5.4 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Product Portfolio
  30. 7.5.5 IBSA Institut Biochimque SA Recent Developments
  31. 7.6 Teh Seng Pharmaceutical Mfg
  32. 7.6.1 Teh Seng Pharmaceutical Mfg Company Information
  33. 7.6.2 Teh Seng Pharmaceutical Mfg Business Overview
  34. 7.6.3 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product Portfolio
  36. 7.6.5 Teh Seng Pharmaceutical Mfg Recent Developments
  37. 7.7 Teikoku Seiyaku Co., Ltd.
  38. 7.7.1 Teikoku Seiyaku Co., Ltd. Company Information
  39. 7.7.2 Teikoku Seiyaku Co., Ltd. Business Overview
  40. 7.7.3 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Product Portfolio
  42. 7.7.5 Teikoku Seiyaku Co., Ltd. Recent Developments
  43. 7.8 GlaxoSmithKline Plc
  44. 7.8.1 GlaxoSmithKline Plc Company Information
  45. 7.8.2 GlaxoSmithKline Plc Business Overview
  46. 7.8.3 GlaxoSmithKline Plc Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  47. 7.8.4 GlaxoSmithKline Plc Non-opioid Analgesic Patch Product Portfolio
  48. 7.8.5 GlaxoSmithKline Plc Recent Developments
  49. 7.9 Pfizer, Inc.
  50. 7.9.1 Pfizer, Inc. Company Information
  51. 7.9.2 Pfizer, Inc. Business Overview
  52. 7.9.3 Pfizer, Inc. Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Pfizer, Inc. Non-opioid Analgesic Patch Product Portfolio
  54. 7.9.5 Pfizer, Inc. Recent Developments
  55. 7.10 Mylan N.V.
  56. 7.10.1 Mylan N.V. Company Information
  57. 7.10.2 Mylan N.V. Business Overview
  58. 7.10.3 Mylan N.V. Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Mylan N.V. Non-opioid Analgesic Patch Product Portfolio
  60. 7.10.5 Mylan N.V. Recent Developments
8 North America
  1. 8.1 North America Non-opioid Analgesic Patch Revenue (2021-2032)
  2. 8.2 North America Non-opioid Analgesic Patch Revenue by Type (2021-2032)
  3. 8.2.1 North America Non-opioid Analgesic Patch Revenue by Type (2021-2026)
  4. 8.2.2 North America Non-opioid Analgesic Patch Revenue by Type (2027-2032)
  5. 8.3 North America Non-opioid Analgesic Patch Revenue Share by Type (2021-2032)
  6. 8.4 North America Non-opioid Analgesic Patch Revenue by Application (2021-2032)
  7. 8.4.1 North America Non-opioid Analgesic Patch Revenue by Application (2021-2026)
  8. 8.4.2 North America Non-opioid Analgesic Patch Revenue by Application (2027-2032)
  9. 8.5 North America Non-opioid Analgesic Patch Revenue Share by Application (2021-2032)
  10. 8.6 North America Non-opioid Analgesic Patch Revenue by Country
  11. 8.6.1 North America Non-opioid Analgesic Patch Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Non-opioid Analgesic Patch Revenue by Country (2021-2026)
  13. 8.6.3 North America Non-opioid Analgesic Patch Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Non-opioid Analgesic Patch Revenue (2021-2032)
  2. 9.2 Europe Non-opioid Analgesic Patch Revenue by Type (2021-2032)
  3. 9.2.1 Europe Non-opioid Analgesic Patch Revenue by Type (2021-2026)
  4. 9.2.2 Europe Non-opioid Analgesic Patch Revenue by Type (2027-2032)
  5. 9.3 Europe Non-opioid Analgesic Patch Revenue Share by Type (2021-2032)
  6. 9.4 Europe Non-opioid Analgesic Patch Revenue by Application (2021-2032)
  7. 9.4.1 Europe Non-opioid Analgesic Patch Revenue by Application (2021-2026)
  8. 9.4.2 Europe Non-opioid Analgesic Patch Revenue by Application (2027-2032)
  9. 9.5 Europe Non-opioid Analgesic Patch Revenue Share by Application (2021-2032)
  10. 9.6 Europe Non-opioid Analgesic Patch Revenue by Country
  11. 9.6.1 Europe Non-opioid Analgesic Patch Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Non-opioid Analgesic Patch Revenue by Country (2021-2026)
  13. 9.6.3 Europe Non-opioid Analgesic Patch Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Non-opioid Analgesic Patch Revenue (2021-2032)
  2. 10.2 China Non-opioid Analgesic Patch Revenue by Type (2021-2032)
  3. 10.2.1 China Non-opioid Analgesic Patch Revenue by Type (2021-2026)
  4. 10.2.2 China Non-opioid Analgesic Patch Revenue by Type (2027-2032)
  5. 10.3 China Non-opioid Analgesic Patch Revenue Share by Type (2021-2032)
  6. 10.4 China Non-opioid Analgesic Patch Revenue by Application (2021-2032)
  7. 10.4.1 China Non-opioid Analgesic Patch Revenue by Application (2021-2026)
  8. 10.4.2 China Non-opioid Analgesic Patch Revenue by Application (2027-2032)
  9. 10.5 China Non-opioid Analgesic Patch Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Non-opioid Analgesic Patch Revenue (2021-2032)
  2. 11.2 Asia Non-opioid Analgesic Patch Revenue by Type (2021-2032)
  3. 11.2.1 Asia Non-opioid Analgesic Patch Revenue by Type (2021-2026)
  4. 11.2.2 Asia Non-opioid Analgesic Patch Revenue by Type (2027-2032)
  5. 11.3 Asia Non-opioid Analgesic Patch Revenue Share by Type (2021-2032)
  6. 11.4 Asia Non-opioid Analgesic Patch Revenue by Application (2021-2032)
  7. 11.4.1 Asia Non-opioid Analgesic Patch Revenue by Application (2021-2026)
  8. 11.4.2 Asia Non-opioid Analgesic Patch Revenue by Application (2027-2032)
  9. 11.5 Asia Non-opioid Analgesic Patch Revenue Share by Application (2021-2032)
  10. 11.6 Asia Non-opioid Analgesic Patch Revenue by Country
  11. 11.6.1 Asia Non-opioid Analgesic Patch Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Non-opioid Analgesic Patch Revenue by Country (2021-2026)
  13. 11.6.3 Asia Non-opioid Analgesic Patch Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Non-opioid Analgesic Patch Revenue (2021-2032)
  2. 12.2 SAMEA Non-opioid Analgesic Patch Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Non-opioid Analgesic Patch Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Non-opioid Analgesic Patch Revenue by Type (2027-2032)
  5. 12.3 SAMEA Non-opioid Analgesic Patch Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Non-opioid Analgesic Patch Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Non-opioid Analgesic Patch Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Non-opioid Analgesic Patch Revenue by Application (2027-2032)
  9. 12.5 SAMEA Non-opioid Analgesic Patch Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Non-opioid Analgesic Patch Revenue by Country
  11. 12.6.1 SAMEA Non-opioid Analgesic Patch Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Non-opioid Analgesic Patch Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Non-opioid Analgesic Patch Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst